Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   lymphangioleiomyomatosis
  

Disease ID 126
Disease lymphangioleiomyomatosis
Definition
rare lung disorder of unknown etiology mostly in women of childbearing age; proliferation of atypical smooth muscle cells in lungs, airways, blood and lymph vessels causing obstruction; symptoms include dyspnea and pneumothorax.
Synonym
lymphangioleiomyomatoses
lymphangioleiomyomatosis [disease/finding]
lymphangiomyomatoses
lymphangiomyomatosis
lymphangiomyomatosis (morphologic abnormality)
Orphanet
OMIM
DOID
ICD10
UMLS
C0751674
MeSH
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:13)
C0041341  |  tuberous sclerosis  |  9
C0041341  |  tuberous sclerosis complex  |  7
C0032326  |  pneumothorax  |  3
C0241961  |  renal angiomyolipoma  |  3
C0041327  |  pulmonary tuberculosis  |  1
C0042133  |  uterine leiomyoma  |  1
C0023267  |  leiomyomas  |  1
C1305409  |  atypical adenoma  |  1
C0041296  |  tuberculosis  |  1
C0013990  |  emphysema  |  1
C0206633  |  angiomyolipomas  |  1
C0024236  |  lymphedema  |  1
C1145670  |  respiratory failure  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:4)
7248  |  TSC1  |  CLINVAR;CTD_human;GHR;ORPHANET;UNIPROT
7249  |  TSC2  |  CLINVAR;CTD_human;GHR;ORPHANET;UNIPROT
3714  |  JAG2  |  CTD_human
3280  |  HES1  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:6)
6347  |  CCL2  |  CIPHER
3280  |  HES1  |  CTD_human
3714  |  JAG2  |  CTD_human
7249  |  TSC2  |  CTD_human
7248  |  TSC1  |  CTD_human
2277  |  FIGF  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:41)
64400  |  AKTIP  |  1.837  |  DISEASES
2909  |  ARHGAP35  |  1.753  |  DISEASES
419  |  ART3  |  2.485  |  DISEASES
116969  |  ART5  |  2.797  |  DISEASES
800  |  CALD1  |  2.411  |  DISEASES
801  |  CALM1  |  1.183  |  DISEASES
55743  |  CHFR  |  1.212  |  DISEASES
9793  |  CKAP5  |  1.977  |  DISEASES
2919  |  CXCL1  |  1.426  |  DISEASES
192668  |  CYS1  |  1.465  |  DISEASES
780  |  DDR1  |  1.106  |  DISEASES
4921  |  DDR2  |  1.141  |  DISEASES
1978  |  EIF4EBP1  |  1.616  |  DISEASES
7430  |  EZR  |  1.225  |  DISEASES
5348  |  FXYD1  |  2.63  |  DISEASES
10457  |  GPNMB  |  1.095  |  DISEASES
3039  |  HBA1  |  1.068  |  DISEASES
3440  |  IFNA2  |  1.224  |  DISEASES
3321  |  IGSF3  |  2.01  |  DISEASES
284252  |  KCTD1  |  1.774  |  DISEASES
2315  |  MLANA  |  3.969  |  DISEASES
4312  |  MMP1  |  1.689  |  DISEASES
4318  |  MMP9  |  1.596  |  DISEASES
2475  |  MTOR  |  5.153  |  DISEASES
727897  |  MUC5B  |  1.058  |  DISEASES
56034  |  PDGFC  |  1.171  |  DISEASES
5241  |  PGR  |  3.388  |  DISEASES
11145  |  PLA2G16  |  1.423  |  DISEASES
6490  |  PMEL  |  3.225  |  DISEASES
64783  |  RBM15  |  1.493  |  DISEASES
387  |  RHOA  |  2.298  |  DISEASES
253260  |  RICTOR  |  2.331  |  DISEASES
6120  |  RPE  |  2.268  |  DISEASES
6194  |  RPS6  |  3.204  |  DISEASES
6840  |  SVIL  |  2.649  |  DISEASES
10460  |  TACC3  |  1.504  |  DISEASES
6949  |  TCOF1  |  1.188  |  DISEASES
80328  |  ULBP2  |  1.481  |  DISEASES
79465  |  ULBP3  |  1.925  |  DISEASES
2837  |  UTS2R  |  1.588  |  DISEASES
7422  |  VEGFA  |  1.211  |  DISEASES
Locus
Symbol | Locus(Total Locus:2)
TSC1  |  9q34
TSC2  |  16p13.3
Disease ID 126
Disease lymphangioleiomyomatosis
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:37)
HP:0005562  |  Multiple renal cysts
HP:0002239  |  Gastrointestinal hemorrhage
HP:0012733  |  Macule
HP:0002094  |  Dyspnea
HP:0012086  |  Abnormal urinary color
HP:0012798  |  Pulmonary lymphangiomyomatosis
HP:0012378  |  Fatigue
HP:0100543  |  Cognitive impairment
HP:0002027  |  Abdominal pain
HP:0001000  |  Abnormality of skin pigmentation
HP:0009594  |  Retinal hamartoma
HP:0001004  |  Lymphedema
HP:0002205  |  Recurrent respiratory infections
HP:0002716  |  Lymphadenopathy
HP:0002091  |  Restrictive lung disease
HP:0002097  |  Emphysema
HP:0009721  |  Shagreen patch
HP:0012798  |  Pulmonary myomatosis
HP:0002113  |  Pulmonary infiltrates
HP:0000790  |  Hematuria
HP:0002105  |  Hemoptysis
HP:0001541  |  Ascites
HP:0000008  |  Abnormality of female internal genitalia
HP:0001250  |  Seizures
HP:0010310  |  Chylothorax
HP:0100750  |  Atelectasis
HP:0002107  |  Pneumothorax
HP:0001945  |  Fever
HP:0100763  |  Abnormality of the lymphatic system
HP:0000648  |  Optic atrophy
HP:0009726  |  Renal neoplasm
HP:0011852  |  Chylopericardium
HP:0012735  |  Cough
HP:0100804  |  Ungual fibroma
HP:0100749  |  Chest pain
HP:0000238  |  Hydrocephalus
HP:0006772  |  Renal angiomyolipoma
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:11)
HP:0002107  |  Collapsed lung  |  3
HP:0006772  |  Angiomyolipoma  |  3
HP:0002664  |  Neoplasia  |  2
HP:0000107  |  Renal cyst  |  1
HP:0200058  |  Angiosarcoma  |  1
HP:0030731  |  Carcinoma  |  1
HP:0001004  |  Lymphatic obstruction  |  1
HP:0000969  |  Dropsy  |  1
HP:0000131  |  Uterine leiomyoma  |  1
HP:0002097  |  Pulmonary emphysema  |  1
HP:0002878  |  Respiratory failure  |  1
Disease ID 126
Disease lymphangioleiomyomatosis
Manually Symptom
UMLS  | Name(Total Manually Symptoms:19)
C1963215  |  pneumothorax
C1962974  |  chylothorax
C1253937  |  pericardial effusion
C1145670  |  respiratory failure
C0748159  |  pulmonary involvement
C0438692  |  vaginal discharge
C0349604  |  intracranial meningiomas
C0241961  |  renal angiomyolipoma
C0206633  |  angiomyolipomas
C0149781  |  spontaneous pneumothorax
C0041341  |  tuberous sclerosis
C0032226  |  pleural disease
C0025286  |  meningiomas
C0024223  |  lymphangiomyoma
C0024223  |  lymphangioleiomyomas
C0024115  |  lung diseases
C0019158  |  hepatitis
C0019079  |  hemoptysis
C0008732  |  chylous ascites
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:6)
C0041341  |  tuberous sclerosis  |  9
C0032326  |  pneumothorax  |  3
C0241961  |  renal angiomyolipoma  |  2
C0024223  |  lymphangioleiomyomas  |  2
C0206633  |  angiomyolipomas  |  1
C1145670  |  respiratory failure  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:7)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs118203387NA7248TSC1umls:C0751674CLINVARNA0.365700279NATSC19132923365CT
rs118203388NA7248TSC1umls:C0751674CLINVARNA0.365700279NATSC19132923361GT
rs137854218NA7249TSC2umls:C0751674CLINVARNA0.576859191NAPKD1;TSC2162088293CGGCTCCGCCACATCAAG-
rs28934872NA7249TSC2umls:C0751674CLINVARNA0.576859191NATSC2162070571GA
rs45483392NA7249TSC2umls:C0751674CLINVARNA0.576859191NATSC2162087897CT
rs45517148NA7249TSC2umls:C0751674CLINVARNA0.576859191NATSC2162060790GA,T
rs45517179NA7249TSC2umls:C0751674CLINVARNA0.576859191NATSC2162064341CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:8)
HP ID HP Name MP ID MP Name Annotation
HP:0005562Multiple renal cystsMP:0000522kidney cortex cystsabnormal membranous sacs appearing in the outer portion of the kidney located between the renal capsule and the renal medulla and involved in ultrafiltration, containing the renal corpuscles, the renal tubules (except for parts of the loop of Henle which
HP:0002239Gastrointestinal hemorrhageMP:0012305umbilical cord hemorrhagebleeding into or from the umbilical cord
HP:0000648Optic atrophyMP:0012506brain atrophyacquired diminution of the size of the brain associated with wasting as from death and reabsorbtion of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal chan
HP:0001000Abnormality of skin pigmentationMP:0009536abnormal interstitial cell of Cajal morphologyany structural anomaly in the type of cell found in the gastrointestinal tract and serving as a pacemaker that triggers gut contraction; ICCs mediate inputs from the enteric nervous system to smooth muscle cells and are thought to be the cells from which
HP:0100763Abnormality of the lymphatic systemMP:0004502decreased incidence of tumors by chemical inductionlower than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens
HP:0002091Restrictive lung diseaseMP:0008714increased lung carcinoma incidencegreater than the expected number of a malignant neoplasm of the ling, arising from epithelial cells, usually glandular or squamous, occurring in a specific population in a given time period
HP:0000008Abnormality of female internal genitaliaMP:0009403increased variability of skeletal muscle fiber sizegreater range or dispersion within a distribution of skeletal muscle fiber size within a muscle compared to controls
HP:0002205Recurrent respiratory infectionsMP:0014182decreased respiratory epithelial sodium ion transmembrane transportdecrease in the directed movement of sodium ions from one side of the respiratory epithelial cell membrane to the other
Mapped by homologous gene(Total Items:32)
HP ID HP Name MP ID MP Name Annotation
HP:0012798Pulmonary lymphangiomyomatosisMP:0013504increased embryonic tissue cell apoptosisincrease in the timing or the number of cells in embryonic tissue undergoing programmed cell death
HP:0012735CoughMP:0014185cerebellum atrophyacquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal
HP:0001945FeverMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
HP:0001250SeizuresMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002205Recurrent respiratory infectionsMP:0020321increased vascular endothelial cell apoptosisincrease in the timing or the number of vascular endothelial cells undergoing programmed cell death
HP:0002113Pulmonary infiltratesMP:0020154impaired humoral immune responseimpaired response of the immune system that mediates secreted antibodies produced in B cells
HP:0000008Abnormality of female internal genitaliaMP:0013785abnormal mammary gland bud morphologyany structural anomaly of the morphologically distinct bulb of epithelial cells formed once each mammary placode expands and invaginates into the underlying mesenchyme; in mouse embryos at E12.5, each epithelial bud with its contiguous mesenchyme is eleva
HP:0001004LymphedemaMP:0014171increased fatty acid oxidationincreased rate or incidence of the process of removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydr
HP:0000238HydrocephalusMP:0020080increased bone mineralizationincrease in the rate at which minerals are deposited into bone
HP:0100763Abnormality of the lymphatic systemMP:0012431increased lymphoma incidencegreater than the expected number of neoplasms characterized by a proliferation of malignant lymphocytes in lymphoid tissue in a specific population in a given time period
HP:0002097EmphysemaMP:0020321increased vascular endothelial cell apoptosisincrease in the timing or the number of vascular endothelial cells undergoing programmed cell death
HP:0100543Cognitive impairmentMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0005562Multiple renal cystsMP:0011108embryonic lethality during organogenesis, incomplete penetrancethe appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms between embryo turning and the completion of organogenesis (Mus: E9-9.5 to less than E14)
HP:0002094DyspneaMP:0014185cerebellum atrophyacquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal
HP:0100750AtelectasisMP:0020321increased vascular endothelial cell apoptosisincrease in the timing or the number of vascular endothelial cells undergoing programmed cell death
HP:0002107PneumothoraxMP:0012080chylous ascitesthe extravasation of milky triglyceride-rich chyle into the peritoneal cavity; often a secondary symptom of neoplasms
HP:0001000Abnormality of skin pigmentationMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0009721Shagreen patchMP:0014171increased fatty acid oxidationincreased rate or incidence of the process of removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydr
HP:0009726Renal neoplasmMP:0014171increased fatty acid oxidationincreased rate or incidence of the process of removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydr
HP:0100804Ungual fibromaMP:0013504increased embryonic tissue cell apoptosisincrease in the timing or the number of cells in embryonic tissue undergoing programmed cell death
HP:0002239Gastrointestinal hemorrhageMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0001541AscitesMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0002105HemoptysisMP:0011098embryonic lethality during organogenesis, complete penetrancedeath of all organisms of a given genotype in a population between embryo turning and the completion of organogenesis (Mus: E9-9.5 to less than E14)
HP:0012378FatigueMP:0013659abnormal erythroid lineage cell morphologyany structural anomaly of an immature or mature cell in the lineage leading to and including erythrocytes
HP:0000790HematuriaMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0006772Renal angiomyolipomaMP:0013504increased embryonic tissue cell apoptosisincrease in the timing or the number of cells in embryonic tissue undergoing programmed cell death
HP:0002027Abdominal painMP:0020220decreased tear productiondecreased production of the amount of fluid produced in the eye
HP:0009594Retinal hamartomaMP:0013504increased embryonic tissue cell apoptosisincrease in the timing or the number of cells in embryonic tissue undergoing programmed cell death
HP:0100749Chest painMP:0020154impaired humoral immune responseimpaired response of the immune system that mediates secreted antibodies produced in B cells
HP:0002716LymphadenopathyMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0000648Optic atrophyMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002091Restrictive lung diseaseMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
Disease ID 126
Disease lymphangioleiomyomatosis
Case(Waiting for update.)